FdaApplication
NDA 022025
Identifiers
- fda_app_no: NDA022025
Properties
| Property | Value |
|---|---|
| applicant_name | CLINIGEN INC |
| application_type | NDA |
| approval_date | 2007-09-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOTECT | DEXRAZOXANE HYDROCHLORIDE | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
1 product